Skip to content

Clinical trials

Hyperkalemia trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperkalemia Country / region: United Kingdom Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20172
20192
20215
20224

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Portsmouth Hospitals NHS Trust2
Barts & The London NHS Trust1
Relypsa, Inc.1
St George's, University of London1
Vifor (International) Inc.1
Vifor Pharma, Inc.1
ZS Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperkalemia14
Renal Insufficiency, Chronic5
Heart Failure3
Hypertension2
Acute Kidney Injury1
Atrial Fibrillation1
Diabetes Mellitus, Type 21
Pseudohypoaldosteronism1
Tachycardia, Ventricular1
Ventricular Dysfunction, Left1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.